Haiyi Hu1, Yuebing Chen2, Sheng Cheng1, Gonghui Li1, Zhigen Zhang1. 1. Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 300016, Hangzhou, Zhejiang, China. 2. Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 300016, Hangzhou, Zhejiang, China. hhypost@126.com.
Abstract
BACKGROUND: The homeobox (HOX) genes have been implicated playing important roles in many human cancers. HOXA13 is a member of HOX genes that encode transcription factors regulating embryonic development and cell fate. In the present study, we aimed to investigate the expression and prognostic significance of HOXA13 in bladder cancer. METHODS: Immunohistochemical staining was initially performed to screen the differentially expressed HOXA13 between bladder cancer tissues and paired adjacent non-cancerous tissues. Subsequent Western blotting analysis validation was conducted using tissue samples from patients with bladder cancer. RESULTS: The expression level of HOXA13 was significantly higher in bladder cancer tissues compared to that in adjacent non-cancerous tissues (P < 0.001). The χ2-test showed that expression of HOXA13 was positively correlated with lymphatic metastasis (P = 0.013), bladder tumor TNM stage (P = 0.002) and pathological grade (P < 0.001). Kaplan-Meier survival analysis revealed that patients with bladder cancer with high expression of HOXA13 had shorter overall survival time (P = 0.001) and disease-free survival time (P = 0.001) compared to patients with low expression of HOXA13. Multivariate analysis indicated that HOXA13 was an independent prognostic factor for overall survival for bladder cancer patients. CONCLUSIONS: The results of our study show that high expression of HOXA13 is associated with the progression of bladder cancer and that HOXA13 might serve as a biomarker for prognosis of bladder cancer.
BACKGROUND: The homeobox (HOX) genes have been implicated playing important roles in many humancancers. HOXA13 is a member of HOX genes that encode transcription factors regulating embryonic development and cell fate. In the present study, we aimed to investigate the expression and prognostic significance of HOXA13 in bladder cancer. METHODS: Immunohistochemical staining was initially performed to screen the differentially expressed HOXA13 between bladder cancer tissues and paired adjacent non-cancerous tissues. Subsequent Western blotting analysis validation was conducted using tissue samples from patients with bladder cancer. RESULTS: The expression level of HOXA13 was significantly higher in bladder cancer tissues compared to that in adjacent non-cancerous tissues (P < 0.001). The χ2-test showed that expression of HOXA13 was positively correlated with lymphatic metastasis (P = 0.013), bladder tumorTNM stage (P = 0.002) and pathological grade (P < 0.001). Kaplan-Meier survival analysis revealed that patients with bladder cancer with high expression of HOXA13 had shorter overall survival time (P = 0.001) and disease-free survival time (P = 0.001) compared to patients with low expression of HOXA13. Multivariate analysis indicated that HOXA13 was an independent prognostic factor for overall survival for bladder cancerpatients. CONCLUSIONS: The results of our study show that high expression of HOXA13 is associated with the progression of bladder cancer and that HOXA13 might serve as a biomarker for prognosis of bladder cancer.
Authors: D Acampora; M D'Esposito; A Faiella; M Pannese; E Migliaccio; F Morelli; A Stornaiuolo; V Nigro; A Simeone; E Boncinelli Journal: Nucleic Acids Res Date: 1989-12-25 Impact factor: 16.971
Authors: Clemente Cillo; Giulia Schiavo; Monica Cantile; Michel P Bihl; Paolo Sorrentino; Vincenza Carafa; Maria D' Armiento; Massimo Roncalli; Sebastiano Sansano; Raffaela Vecchione; Luigi Tornillo; Lucia Mori; Gennaro De Libero; Jessica Zucman-Rossi; Luigi Terracciano Journal: Int J Cancer Date: 2011-05-30 Impact factor: 7.396
Authors: Andrew Holyoake; Paul O'Sullivan; Rob Pollock; Terry Best; Jun Watanabe; Yoichiro Kajita; Yoshiyuki Matsui; Masaaki Ito; Hiroyuki Nishiyama; Natalie Kerr; Fernanda da Silva Tatley; Lisa Cambridge; Tumi Toro; Osamu Ogawa; Parry Guilford Journal: Clin Cancer Res Date: 2008-02-01 Impact factor: 12.531
Authors: Richard Morgan; Angie Boxall; Kevin J Harrington; Guy R Simpson; Agnieszka Michael; Hardev S Pandha Journal: BMC Urol Date: 2014-02-05 Impact factor: 2.264